CJC-1295 with DAC, 2mg

A synthetic modified peptide molecule designed for laboratory study is called CJC-1295 with DAC. The molecule’s stability under experimental conditions is improved via a Drug Affinity Complex (DAC) modification. In controlled settings, laboratory studies show particular molecular pathway connections and unique binding characteristics. According to in vitro research, the compound’s 30-amino acid sequence structure demonstrates specific receptor affinity. Compared to the unmodified version, the DAC alteration permits longer stability in solution, which makes it especially appropriate for protracted laboratory investigations.